DLH - DLHC Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DLH in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" DLH stock.
View analyst ratings for DLH or view top-rated stocks.

1 brokerages have issued 12-month price objectives for DLH's stock. Their DLHC stock forecasts range from $14.00 to $14.00. On average, they predict DLH's share price to reach $14.00 in the next year. This suggests that the stock has a possible downside of 21.9%.
View analysts' price targets for DLH or view top-rated stocks among Wall Street analysts.

DLH's stock was trading at $20.72 on January 1st, 2022. Since then, DLHC stock has decreased by 13.5% and is now trading at $17.93.
View the best growth stocks for 2022 here.

DLH saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 85,200 shares, a decrease of 21.1% from the June 30th total of 108,000 shares. Based on an average daily volume of 28,300 shares, the short-interest ratio is presently 3.0 days. Approximately 0.9% of the shares of the stock are short sold.
View DLH's Short Interest.

DLH is scheduled to release its next quarterly earnings announcement on Monday, December 5th 2022.
View our earnings forecast for DLH.

DLH Holdings Corp. (NASDAQ:DLHC) released its quarterly earnings data on Tuesday, August, 2nd. The business services provider reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.11. DLH had a trailing twelve-month return on equity of 24.55% and a net margin of 5.78%. During the same quarter in the previous year, the business posted $0.21 earnings per share.

Based on aggregate information from My MarketBeat watchlists, some companies that other DLH investors own include Enterprise Products Partners (EPD), Ford Motor (F), Gilead Sciences (GILD), Invesco (IVZ), Netflix (NFLX), Omega Healthcare Investors (OHI), Pfizer (PFE), United Microelectronics (UMC), AbbVie (ABBV) and Activision Blizzard (ATVI).

DLH trades on the NASDAQ under the ticker symbol "DLHC."

DLH's stock is owned by many different institutional and retail investors. Top institutional investors include Albert D Mason Inc. (0.75%), Aprio Wealth Management LLC (0.16%), Bailard Inc. (0.09%), Denali Advisors LLC (0.05%), Denali Advisors LLC (0.05%) and Victory Capital Management Inc. (0.04%). Company insiders that own DLH stock include Frederick Gerald Wasserman, Kathryn M Johnbull, Kevin Wilson, Stephen Zelkowicz, William H Alderman, Wynnefield Partners Small Cap and Zachary Parker.
View institutional ownership trends for DLH.

Shares of DLHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DLHC stock can currently be purchased for approximately $17.93.

DLH (NASDAQ:DLHC) has a market capitalization of $232.37 million and generates $246.09 million in revenue each year. The business services provider earns $10.15 million in net income (profit) each year or $1.60 on an earnings per share basis.

DLH employs 2,300 workers across the globe.

DLH's mailing address is 3565 Piedmont Road NE Building 3 Suite 700, Atlanta GA, 30305. The official website for DLH is www.dlhcorp.com. The business services provider can be reached via phone at (770) 554-3545 or via email at investorrelations@dlhcorp.com.